Bundamedik Tbk vs Fore Kopi Indonesia Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Fore Kopi Indonesia Tbk. trades at Rp615 (market cap 5.44T, 1.89M 24h volume). The key difference: Fore Kopi Indonesia Tbk. is far larger — about 3.6× Bundamedik Tbk's market cap, and Fore Kopi Indonesia Tbk. is more actively traded (1.89M versus 536.7K). Which is the better fit depends on your goals.
| BMHS | FORE | |
|---|---|---|
Market Cap | 1.51T | 5.44T |
Volume | 536.7K | 1.89M |
Lot | 5.37K | 18.9K |
Turnover | 93.41M | 1.15B |
Average Price | 174.05 | 609.92 |
Value | 93.41M | 1.15B |
Indicative Equilibrium Price | 176 | 615 |
Indicative Equilibrium Volume | 100 | 1.29K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.
Read more on FORE →